{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:22:55Z","timestamp":1780514575366,"version":"3.54.1"},"reference-count":30,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2014\/03989-6"],"award-info":[{"award-number":["2014\/03989-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypercortisolism induces immunosuppression, and infections represent the second leading cause of death among patients with Cushing syndrome. We report the case of an adult man with a silent corticotroph pituitary adenoma that evolved into a functioning adrenocorticotropic hormone-secreting tumor. The patient had diabetes mellitus and was treated with dapagliflozin. Prior to transsphenoidal adenomectomy, he developed Fournier gangrene, a necrotizing fasciitis of the perineal and genital regions. Infectious management included debridement, antibiotics, and hyperbaric oxygen therapy. After adequate control of the infection, pituitary surgery was performed, resulting in hypercortisolism remission. Although Cushing syndrome is well known to predispose patients to infections, the association between endogenous hypercortisolism and Fournier gangrene has been scarcely described in the literature. The present case highlights the risk of this severe soft tissue infection in patients with Cushing syndrome. Dapagliflozin and other sodium\u2013glucose cotransporter 2 inhibitors have been investigated as potential contributors to Fournier gangrene in patients with diabetes mellitus, prompting a discussion about the safety of prescribing these agents in the setting of hypercortisolism.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag133","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:56:28Z","timestamp":1777377388000},"source":"Crossref","is-referenced-by-count":1,"title":["Fournier gangrene in a patient with corticotrophinoma and diabetes treated with sodium\u2013glucose cotransporter 2 inhibitor"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8684-2799","authenticated-orcid":false,"given":"Beatriz Yukie Kagohara","family":"Elias","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto 14048-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Cond\u00e9 Lamparelli","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto 14048-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9 Albuquerque","family":"de Paula","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto 14048-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-6803","authenticated-orcid":false,"given":"Ayrton Custodio","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto 14048-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marley Ribeiro","family":"Feitosa","sequence":"additional","affiliation":[{"name":"Department of Surgery and Anatomy, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto 14048-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-4623","authenticated-orcid":false,"given":"Margaret","family":"de Castro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto 14048-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"8","key":"2026052007564861400_luag133-B1","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","article-title":"The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality","volume":"107","author":"Limumpornpetch","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026052007564861400_luag133-B2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.idc.2007.06.001","article-title":"Hypercortisolemia and infection","volume":"21","author":"Fareau","year":"2007","journal-title":"Infect Dis Clin North Am"},{"issue":"S1","key":"2026052007564861400_luag133-B3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40618-024-02454-8","article-title":"Unusual infections and thrombotic events in Cushing's syndrome","volume":"48","author":"Barbot","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2026052007564861400_luag133-B4","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.juro.2009.01.034","article-title":"Fournier's gangrene: population based epidemiology and outcomes","volume":"181","author":"Sorensen","year":"2009","journal-title":"J Urol"},{"issue":"3","key":"2026052007564861400_luag133-B5","doi-asserted-by":"crossref","DOI":"10.4081\/aiua.2016.3.157","article-title":"Fournier's gangrene: a clinical review","volume":"88","author":"Singh","year":"2016","journal-title":"Arch Ital Urol Androl"},{"issue":"7","key":"2026052007564861400_luag133-B6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF02554101","article-title":"Gangrene of male external genitalia in a patient with colorectal disease: anatomic pathways of spread","volume":"28","author":"Khan","year":"1985","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"2026052007564861400_luag133-B7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1442-2042.2006.01448.x","article-title":"Fournier's gangrene: report of thirty-three cases and a review of the literature","volume":"13","author":"Tahmaz","year":"2006","journal-title":"Int J Urol"},{"issue":"3","key":"2026052007564861400_luag133-B8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1479-666X(09)80036-X","article-title":"Fournier's gangrene: a dreadful disease","volume":"7","author":"Ullah","year":"2009","journal-title":"Surgeon"},{"issue":"5","key":"2026052007564861400_luag133-B9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0090-4295(02)01951-9","article-title":"Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangrene","volume":"60","author":"Nisbet","year":"2002","journal-title":"Urology"},{"issue":"1","key":"2026052007564861400_luag133-B10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000725","article-title":"Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors","volume":"7","author":"Fadini","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026052007564861400_luag133-B11","first-page":"1","article-title":"Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a pharmacovigilance study with data from the U.S. FDA adverse event reporting system","volume":"2020","author":"Hu","year":"2020","journal-title":"J Diabetes Res"},{"issue":"1","key":"2026052007564861400_luag133-B12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000985","article-title":"Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangrene","volume":"8","author":"Yang","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"8","key":"2026052007564861400_luag133-B13","article-title":"Fournier's gangrene: a coexistence or consanguinity of SGLT-2 inhibitor therapy","volume":"14","author":"Chowdhury","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"2026052007564861400_luag133-B14","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-6-405","article-title":"Adrenocortical carcinoma initially presenting with hypokalemia and hypertension mimicking hyperaldosteronism: a case report","volume":"6","author":"Huang","year":"2013","journal-title":"BMC Res Notes"},{"key":"2026052007564861400_luag133-B15","doi-asserted-by":"crossref","DOI":"10.4137\/CMED.S39997","article-title":"No postoperative adrenal insufficiency in a patient with unilateral cortisol-secreting adenomas treated with mifepristone before surgery","volume":"9","author":"Saroka","year":"2016","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"2","key":"2026052007564861400_luag133-B16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","article-title":"Silent corticotroph adenomas","volume":"21","author":"Ben-Shlomo","year":"2018","journal-title":"Pituitary"},{"key":"2026052007564861400_luag133-B17","first-page":"137","article-title":"The basophil adenoma of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hospital"},{"issue":"5","key":"2026052007564861400_luag133-B18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11102-023-01343-2","article-title":"Complications and mortality of Cushing's disease: report on data collected over a 20-year period at a referral centre","volume":"26","author":"Mondin","year":"2023","journal-title":"Pituitary"},{"issue":"2","key":"2026052007564861400_luag133-B19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12020-021-02768-0","article-title":"Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort","volume":"74","author":"Toivanen","year":"2021","journal-title":"Endocrine"},{"issue":"5","key":"2026052007564861400_luag133-B20","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.1210\/clinem\/dgab058","article-title":"Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality","volume":"106","author":"Schernthaner-Reiter","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026052007564861400_luag133-B21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cen.12299","article-title":"Diagnosis and complications of Cushing's disease: gender-related differences","volume":"80","author":"Zilio","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"5","key":"2026052007564861400_luag133-B22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026052007564861400_luag133-B23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026052007564861400_luag133-B24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11934-025-01275-3","article-title":"Modern management of Fournier's gangrene","volume":"26","author":"Kopechek","year":"2025","journal-title":"Curr Urol Rep"},{"issue":"5","key":"2026052007564861400_luag133-B25","doi-asserted-by":"crossref","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","article-title":"European Society of Endocrinology and endocrine society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency","volume":"190","author":"Beuschlein","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"22","key":"2026052007564861400_luag133-B26","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"2026052007564861400_luag133-B27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"2026052007564861400_luag133-B28","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s13300-024-01613-7","article-title":"Risk of urogenital bacterial infection with sodium-glucose cotransporter-2 inhibitors: a retrospective cohort study using a claims database","volume":"15","author":"Imai","year":"2024","journal-title":"Diabetes Ther"},{"key":"2026052007564861400_luag133-B29","author":"U.S. Food and Drug Administration"},{"issue":"8","key":"2026052007564861400_luag133-B30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/dtb.2019.000032","article-title":"MHRA drug safety update: risk of Fournier's gangrene with SGLT2 inhibitors for diabetes","volume":"57","author":"DTB Team","year":"2019","journal-title":"Drug Ther Bull"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/6\/luag133\/68273570\/luag133.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/6\/luag133\/68273570\/luag133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:57:06Z","timestamp":1779278226000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag133\/8676520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,4,29]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag133","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,29]]},"article-number":"luag133"}}